mTOR as a multifunctional therapeutic target in HIV infection
Ferdinando Nicoletti(University of Catania), Klaus Bendtzen(Rigshospitalet), Paolo Fagone(University of Catania), James A. McCubrey(East Carolina University), Pier Luigi Meroni(IRCCS Istituto Auxologico Italiano)
Cited by 99
Related Papers
International consensus statement on an update of the classification criteria for definite antiphospholipid syndrome (APS)
|Journal of Thrombosis and Haemostasis|2006|7.1k
Natural products in drug discovery: advances and opportunities
|Nature Reviews Drug Discovery|2021|5.2k
Ras/Raf/MEK/ERK and PI3K/PTEN/Akt/mTOR Inhibitors: Rationale and Importance to Inhibiting These Pathways in Human Health
|Oncotarget|2011|579
GSK-3 as potential target for therapeutic intervention in cancer
|Oncotarget|2014|508